RE: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.

ABSTRACT:

SUBMITTER: Freidlin B 

PROVIDER: S-EPMC5072374 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature